Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer-Reference-Cited by-同舟云学术

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

Published:2004-03 Issue:4 Volume:40 Page:536-542
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Fumoleau P.,Largillier R.,Clippe C.,Dièras V.,Orfeuvre H.,Lesimple T.,Culine S.,Audhuy B.,Serin D.,Curé H.,Vuillemin E.,Morère J.-F.,Montestruc F.,Mouri Z.,Namer M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Adjuvant therapy for breast cancer—results from the USA consensus conference;Abrams;Breast Cancer,2001

2. Adjuvant therapy of primary breast cancer: a review of key findings from the 7th International Conference, St. Gallen, February 2001;Aapro;Oncologist,2001

3. Experience at the Istituto Nazionale Tumori with paclitaxel in combination with doxorubicin in women with untreated breast cancer;Gianni;Semin Oncol,1997

4. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer;Lück;Semin Oncol,1997

5. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group;Nabholtz;J Clin Oncol,1999

Cited by 271 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome;2024-08-09

2. Mexican breast cancer consensus. Management of advanced breast cancer;Gaceta Mexicana de Oncolog�a;2024-06-25

3. A Representative Clinical Course of Progression, with Molecular Insights, of Hormone Receptor-Positive, HER2-Negative Bone Metastatic Breast Cancer;International Journal of Molecular Sciences;2024-03-17

4. Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy;Medical Oncology;2023-12-16

5. Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma;The Oncologist;2023-12-09